UBS (Lux) Equity Fund - Biotech (USD) (EUR) Q-acc, EUR/ LU1769088235 /
NAV6/12/2024 | Chg.-0.2600 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
102.7200EUR | -0.25% | reinvestment | Equity Worldwide | UBS Fund M. (LU) ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | - | -3.68 | -1.52 | -0.89 | 0.80 | -1.18 | 1.59 | -0.27 | -1.65 | -8.67 | 1.83 | 14.50 | -1.72% |
2024 | -1.14 | -0.19 | 2.05 | -7.43 | 7.63 | 3.59 | - | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 19.15% | 20.73% | 19.04% | -% | -% |
Sharpe ratio | 0.28 | 1.13 | 0.14 | - | - |
Best month | +14.50% | +14.50% | +14.50% | - | - |
Worst month | -7.43% | -7.43% | -8.67% | - | - |
Maximum loss | -12.74% | -12.74% | -14.72% | - | - |
Outperformance | - | - | - | - | - |
All quotes in EUR
Share classes
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
UBS(Lux)E.F.-Biotech(USD)P a.SEK | reinvestment | 958.6600 | +1.33% | +8.48% | |
UBS(Lux)E.F.-Biotech(USD)QL a.US... | reinvestment | 105.0200 | +7.65% | -9.08% | |
UBS(Lux)E.F.-Biotech(USD)Q a.USD | reinvestment | 322.9800 | +7.43% | -9.62% | |
UBS (Lux) Equity Fund - Biotech ... | reinvestment | 102.7200 | +6.45% | - | |
UBS (Lux) Equity Fund - Biotech ... | reinvestment | 728.4700 | +6.34% | -12.34% |
Performance
YTD | +3.93% | ||
---|---|---|---|
6 Months | +12.74% | ||
1 Year | +6.45% | ||
3 Years | - | ||
5 Years | - | ||
10 Years | - | ||
Since start | +2.14% | ||
Year | |||
2023 | -1.72% |